Investment Rating - The industry rating is "Outperform the Market," indicating that the overall return of the industry is expected to exceed the market benchmark index by more than 5% in the next 6 months [14]. Core Insights - Recently, the company completed a strategic financing round of 500 million yuan, led by Alibaba, with participation from Guotou Chuanghe and continued support from Tencent, bringing the total financing in the past year to over 1.1 billion yuan [3]. - The financing will significantly accelerate the clinical progress of the company, aiming to complete the first domestic clinical implantation of a 256-channel wireless high-throughput invasive brain-computer interface system by early 2026, which is the only invasive brain-computer interface product in China's regulatory green channel [3]. - The company plans to conduct large-scale multi-center registration clinical trials in mid-2026, with an expected total of 40 patient implantations within the year, potentially surpassing Neuralink by the end of the year [3]. - The company, established in 2021, is a hard-tech enterprise in the field of minimally invasive brain-computer interfaces, possessing globally leading technologies in electrodes and surgical robots, and is focused on "brain control" and "neuroregulation" [4]. - Major tech companies like Alibaba and Tencent entering the field will integrate with the company's hardware barriers and clinical experience to build a new generation of intelligent brain-computer interface systems and application ecosystems [4]. - The brain-computer interface market is projected to grow rapidly, with the global market size expected to reach approximately 2.62 billion USD in 2024 and 2.94 billion USD in 2025, potentially reaching 12.4 billion USD by 2034, with a compound annual growth rate of 17.35% over the next decade [5]. - In China, the brain-computer interface market is expected to grow from 3.2 billion yuan in 2024 to 6.14 billion yuan by 2028, supported by national strategic planning to promote brain-computer interfaces as a new economic growth point [5]. - The report suggests paying attention to companies such as Yanshan Technology, Hanwei Technology, Sanbo Brain Science, and others in the sector [5].